SHANDONG BOAN BIOTECH.H 1 (UJ9) — Cash Flow Reinvestment Rate

Latest as of December 2025: 4.22x

SHANDONG BOAN BIOTECH.H 1 (UJ9) has a Cash Flow Reinvestment Rate of 4.22x as of December 2025, reinvesting €274.05 Million (capex €274.05 Million ) from operating cash flow of €64.89 Million. Check how high is SHANDONG BOAN BIOTECH.H 1's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

4.22x

(Capex + Investments) / Operating CF

Total Reinvested

€274.05 Million

Capex + Investments

Operating Cash Flow

€64.89 Million

EUR

Capital Expenditures

€274.05 Million

EUR

SHANDONG BOAN BIOTECH.H 1 Cash Flow Reinvestment Rate (2025–2025)

Historical reinvestment intensity for SHANDONG BOAN BIOTECH.H 1 across 1 annual periods. Explore cash flow to debt ratio of SHANDONG BOAN BIOTECH.H 1 to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for SHANDONG BOAN BIOTECH.H 1 (2025–2025)

Year-by-year capital reinvestment analysis for SHANDONG BOAN BIOTECH.H 1. For live market cap and broader valuation context, see market cap of SHANDONG BOAN BIOTECH.H 1.

Year	Reinvestment Rate	Total Reinvested (EUR)	Operating CF	Capex	YoY Change
2025	4.22x	€274.05 Million	€64.89 Million	€274.05 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow